2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1619158318 M.D.
Verify on CMS →

Angelita Beredo, M.D.

Endocrinology, Diabetes & Metabolism Physician in Inglewood, California.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
7K
Medicare Part D claims · 483 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
61%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.3/100
▼ 1 pts below national avg 83.5 · Above neutral
Industry payments
$1.7K
76 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Angelita Beredo, M.D. reported a CMS MIPS final score of 82.3/100 - below the 83.5 national average - and filed 7,263 Medicare Part D claims in 2023.

82.3/100
MIPS score · -1 vs avg
7K
Part D claims, 2023
61%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

CMS NPPES provider registry desk

NPI 1619158318 · Endocrinology, Diabetes & Metabolism Physician

NPI-10 · ENUM-MID · TAX-MID · MIPS-INLINE · RX-MID · BOOK-LIGHT · PHOTO-FINISH

  • NPI-10 1619158318
  • ENUM-MID 2007
  • TAX-MID 8K Endocrinology, Diabetes
  • MIPS-INLINE 82.3/100
  • RX-MID 7,263
  • BOOK-LIGHT 879 in California
  • PHOTO-FINISH Hind Alameddine · ±0.0

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Angelita Beredo, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

82 ≥ 36th percentile 36% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). Below this entry. 80–90: 129,887 measured providers (29%). This entry sits in this band. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Angelita Beredo, M.D. sits

This provider among endocrinology, diabetes & metabolism physician peers

Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Angelita Beredo, M.D. writes more Part D claims than 92% of them and scores higher on MIPS quality than 37% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality02550751000255075100Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 3Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 48Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 98Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 22Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 98Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 68Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 93Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 50Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 55Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 97Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 15Angelita Beredo, M.D., Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 37
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Angelita Beredo, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Angelita Beredo, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Angelita Beredo, M.D.?

Near national average

NPI registry status

Active

Issued 11/21/2007

NPI 1619158318

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,871 US NPIs in this specialty

Medicare Part D claims

7,263 175% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

82.3/100 1.2 pts vs avg

Above neutral band

vs 83.5 national avg

Specialty distribution in California

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among California providers

California providers
Behavior Technician17.3%Marriage & Family Therapist5.5%Student in an Organized Heal…5%Mental Health Counselor3.9%Pharmacist3.5%Clinical Social Worker3.1%Endocrinology, Diabetes & Me…0.1%
Largest specialties in California (% of in-state providers)

Medicare quality performance, MIPS

Angelita Beredo, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Near national average
MIPS Final Score
82.3/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%82.3%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 82.3/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

323 N PRAIRIE AVE
Inglewood, CA 90301

Provider Details

NPI 1619158318
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 11/21/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.3406
Final Score
Measured-score avg: 83.5
63.3977
Quality
70.9575
Cost
71
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Angelita Beredo, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.7K

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - California MBC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Angelita Beredo, M.D.. To verify Angelita Beredo, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Angelita Beredo, M.D. - brand share 35.0%
Endocrinology, Diabetes & Metabolism Physician average

35% brand-name claims vs 61% generic, on 7,263 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,263
Total Claims
$2.7M
Total Drug Cost
483
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
14,454
Total Day Supply
428,052
Brand vs Generic
35% brand / 61% generic
Brand Drug Cost
$2.5M
Generic Drug Cost
$141K
Opioid Claims
19 (0.3% rate)
Antibiotic Claims
49

Patient Demographics

Average Patient Age
71.7 years
Avg HCC Risk Score
1.54
Gender Split
71% female / 29% male
Age Distribution
<65: 62, 65-74: 261, 75-84: 131, 85+: 29

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Angelita Beredo, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Farxiga
Dapagliflozin Propanediol
445
Amlodipine Besylate
399
Levothyroxine Sodium
392
Atorvastatin Calcium
276
Metformin Hcl
236
Trulicity
Dulaglutide
193
Losartan Potassium
180
Montelukast Sodium
175
Rosuvastatin Calcium
156
Pravastatin Sodium
155

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Angelita Beredo, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

Angelita Beredo, M.D.'s 7,263 claims are above the specialty average of 2,639.

Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Beredo, both outside California so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (82.3 here).

Same NPPES enumeration year (2007)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Beredo.

One of 879 Endocrinology, Diabetes & Metabolism Physician providers enrolled in California, 5 are shown here.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Angelita Beredo, M.D.'s specialty?
Angelita Beredo, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Inglewood, California. Credentials: M.D..
How much does Angelita Beredo, M.D. prescribe under Medicare Part D?
In 2023, Angelita Beredo, M.D. wrote 7,263 Medicare Part D claims totaling $2.7M in drug costs for 483 beneficiaries.
What is Angelita Beredo, M.D.'s Medicare quality score?
Angelita Beredo, M.D. has a CMS MIPS Final Score of 82.3/100 (Quality: 63.4, Cost: 71). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Angelita Beredo, M.D. located?
Angelita Beredo, M.D. is located at 323 N PRAIRIE AVE, Inglewood, CA, 90301. Phone: (310) 671-2699.
What is Angelita Beredo, M.D.'s NPI number?
Angelita Beredo, M.D.'s National Provider Identifier (NPI) is 1619158318, issued on 11/21/2007.
Does Angelita Beredo, M.D. prescribe more brand-name or generic drugs?
Angelita Beredo, M.D.'s prescribing is 35% brand-name and 61% generic drugs by claim count, with $2.5M in brand drug costs.
Does Angelita Beredo, M.D. prescribe opioids?
Yes, Angelita Beredo, M.D. had 19 opioid claims in 2023 with an opioid prescribing rate of 0.3%.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Angelita Beredo, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Angelita Beredo, M.D.'s most frequently prescribed drugs include Farxiga, Amlodipine Besylate, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Angelita Beredo, M.D. accept Medicare?
Angelita Beredo, M.D. appears in CMS Medicare data with 7,263 Part D claims and 483 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Angelita Beredo, M.D.'s credentials?
Angelita Beredo, M.D.'s NPI is 1619158318 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.